Q2 FY26 · Ended Jun 30, 2026 · View SEC filing
China earns far richer margins than Developed Markets
The fastest-growing region is also the most profitable, so its rising share of sales shifts profit toward China.
For investorsWhat Greater China's growth depends on from here
For foundersSelling trusted old brands where patients choose
Gross profit rose 9.3% on product mix, but a divestiture charge, litigation and R&D absorbed nearly all of it.
Free cash flow was 8.8% of revenue in a loss quarter: writing down acquired products is a cost, not a cash payment.
The top ten products made about 38% of net sales, so most revenue comes from a long tail of medicines.
Unlock the financial breakdown, competitive insights, historical trends and founder playbook, plus research across the company library.
Free CXProWealth membership required
Business Lens describes Viatris from its own filings with the SEC. It is not a view on its shares, a target, or advice to buy, sell or hold anything; figures are as filed and may be restated by the company later. The filing is linked above.
